The first stop for professional medicines advice

Intrathecal medicines

29 results

RelevanceNewest firstOldest firstTitle
Applied filters

Bupivacaine: informing intrathecal risk assessment

11 August 2022Bupivacaine products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Trastuzumab: informing intrathecal risk assessment

11 August 2022Trastuzumab products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Ziconotide: informing intrathecal risk assessment

11 August 2022Ziconotide products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Levobupivacaine: informing intrathecal risk assessment

11 August 2022Levobupivacaine products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Vancomycin: informing intrathecal risk assessment

11 August 2022Vancomycin products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Amikacin: informing intrathecal risk assessment

11 August 2022Amikacin products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Thiotepa: informing intrathecal risk assessment

11 August 2022Thiotepa products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Clonidine: informing intrathecal risk assessment

11 August 2022Clonidine products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Pharmacy Intrathecal Chemotherapy Audit Aide Memoire 4th Edition (Yellow Cover)

24 May 2010This audit document is intended to be used to audit Pharmacy aspects of the safe administration of intrathecal chemotherapy, as part of the EL(97)52 Audit…